Home Newsfeeds Credit Suisse Assumes FirstCash Hldgs at Neutral, Announces Price Target of $88

Credit Suisse Assumes FirstCash Hldgs at Neutral, Announces Price Target of $88

Credit Suisse analyst Moshe Orenbuch assumes FirstCash Hldgs (NASDAQ:FCFS) with a Neutral rating and announces Price Target of $88.

byBenzinga Newsdesk

December 14, 2022

1 minute read

Credit Suisse analyst Moshe Orenbuch assumes FirstCash Hldgs (NASDAQ:FCFS) with a Neutral rating and announces Price Target of $88.

ARS Pharma Readies Data In Response To FDA’s Rejection For Its EpiPen Alternative For Severe Allergic Reactions

By Vandana Singh

February 20, 3:53 PM

NAC study results by ARS Pharma comparing neffy (epinephrine nasal spray) to intramuscular injection. Data submission is expected in Q2 2024.

SPRY

Piper Sandler Maintains Neutral on Westlake, Lowers Price Target to $110

By Benzinga Newsdesk

October 10, 10:16 AM

Piper Sandler analyst Charles Neivert maintains Westlake (NYSE:WLK) with a Neutral and lowers the price target from $115 to $110.

WLK

Phibro Animal Health Corporation Announces Glenn C. David Has Joined Phibro And Will Assume The Role Of Chief Financial Officer Effective February 9, 2024

By Benzinga Newsdesk

February 6, 9:37 AM

Phibro Animal Health Corporation (NASDAQ:PAHC) (the "Company" or "Phibro") today announced that Glenn C. David has joined Phibro and will assume the role of Chief Financial Officer effective February 9, 2024. Mr. Richard

PAHC

Capstone Green Energy Secures Order For C1000S Microturbine For Industrial Dairy Plant In Colombia; No Financial Terms Disclosed

By Happy Mohamed

May 31, 8:31 AM

Installation Provides Innovative Solution for Enhanced Operational Efficiency Capstone Green Energy Corporation (NASDAQ:CGRN), a global leader in carbon reduction and on-site resilient green Energy-as-a-Service

CGRN

Credit Suisse Assumes FirstCash Hldgs at Neutral, Announces Price Target of $88

Related Posts

ARS Pharma Readies Data In Response To FDA’s Rejection For Its EpiPen Alternative For Severe Allergic Reactions

Piper Sandler Maintains Neutral on Westlake, Lowers Price Target to $110

Phibro Animal Health Corporation Announces Glenn C. David Has Joined Phibro And Will Assume The Role Of Chief Financial Officer Effective February 9, 2024

Capstone Green Energy Secures Order For C1000S Microturbine For Industrial Dairy Plant In Colombia; No Financial Terms Disclosed